HIV drug resistance to integrase inhibitors in low- and middle-income countries

Nat Med. 2024 Mar;30(3):618-619. doi: 10.1038/s41591-023-02763-0.

Joseph Fokam^{1

2

3

4}, Seth Inzaule⁵, Vittorio Colizzi⁶, Carlo-Federico Perno^{1

7}, Jean Kaseya⁸, Nicaise Ndembi^{9

10

11}

¹ Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management, Yaoundé, Cameroon.
² Faculty of Health Sciences, University of Buea, Buea, Cameroon.
³ National HIV Drug Resistance Group, Ministry of Public Health, Yaoundé, Cameroon.
⁴ Faculty of Medicine and Biomedical Sciences, University of Yaoundé-I, Yaoundé, Cameroon.
⁵ Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.
⁶ UNESCO Board of Biotechnology, University of Rome Tor Vergata, Rome, Italy.
⁷ Bambino Gesù IRCCS Pediatric Hospital, Rome, Italy.
⁸ Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.
⁹ Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia. nicaise.ndembi@ihv.umaryland.edu.
¹⁰ Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA. nicaise.ndembi@ihv.umaryland.edu.
¹¹ Kanazawa University, Graduate School of Medical Sciences, Ishikawa, Japan. nicaise.ndembi@ihv.umaryland.edu.

No abstract available

Publication types